LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study

Gudrun Piringer; Thomas Gruenberger; Josef Thaler; Irene Kührer; Klaus Kaczirek; Friedrich Längle; Istvan Viragos-Toth; Arno Amann; Wolfgang Eisterer; Reinhold Függer; J. Andel; Angelika Pichler; J Stift; Lidija Sölkner; Michael Gnant; Dietmar Öfner

doi:10.3389/fonc.2023.1231600

LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study

Gudrun Piringer, Thomas Gruenberger, Josef Thaler, Irene Kührer, Klaus Kaczirek, Friedrich Längle, Istvan Viragos-Toth, Arno Amann, Wolfgang Eisterer, Reinhold Függer, J. Andel, Angelika Pichler, J Stift, Lidija Sölkner, Michael Gnant, Dietmar Öfner

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	1231600
Number of pages	11
Journal	Frontiers in oncology
Volume	13
DOIs	https://doi.org/10.3389/fonc.2023.1231600
Publication status	Published - Aug 2023

Fields of science

302024 Haematology
302055 Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fonc.2023.1231600

Cite this

Piringer, G., Gruenberger, T., Thaler, J., Kührer, I., Kaczirek, K., Längle, F., Viragos-Toth, I., Amann, A., Eisterer, W., Függer, R., Andel, J., Pichler, A., Stift, J., Sölkner, L., Gnant, M., & Öfner, D. (2023). LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study. Frontiers in oncology, 13, Article 1231600. https://doi.org/10.3389/fonc.2023.1231600

@article{71bc052d3409405f9067f6474d3bf275,

title = "LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study",

author = "Gudrun Piringer and Thomas Gruenberger and Josef Thaler and Irene K{\"u}hrer and Klaus Kaczirek and Friedrich L{\"a}ngle and Istvan Viragos-Toth and Arno Amann and Wolfgang Eisterer and Reinhold F{\"u}gger and J. Andel and Angelika Pichler and J Stift and Lidija S{\"o}lkner and Michael Gnant and Dietmar {\"O}fner",

year = "2023",

month = aug,

doi = "10.3389/fonc.2023.1231600",

language = "English",

volume = "13",

journal = "Frontiers in oncology",

}

Piringer, G, Gruenberger, T, Thaler, J, Kührer, I, Kaczirek, K, Längle, F, Viragos-Toth, I, Amann, A, Eisterer, W, Függer, R, Andel, J, Pichler, A, Stift, J, Sölkner, L, Gnant, M & Öfner, D 2023, 'LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study', Frontiers in oncology, vol. 13, 1231600. https://doi.org/10.3389/fonc.2023.1231600

TY - JOUR

T1 - LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study

AU - Piringer, Gudrun

AU - Gruenberger, Thomas

AU - Thaler, Josef

AU - Kührer, Irene

AU - Kaczirek, Klaus

AU - Längle, Friedrich

AU - Viragos-Toth, Istvan

AU - Amann, Arno

AU - Eisterer, Wolfgang

AU - Függer, Reinhold

AU - Andel, J.

AU - Pichler, Angelika

AU - Stift, J

AU - Sölkner, Lidija

AU - Gnant, Michael

AU - Öfner, Dietmar

PY - 2023/8

Y1 - 2023/8

UR - https://www.scopus.com/pages/publications/85168712826

U2 - 10.3389/fonc.2023.1231600

DO - 10.3389/fonc.2023.1231600

M3 - Article

VL - 13

JO - Frontiers in oncology

JF - Frontiers in oncology

M1 - 1231600

ER -

LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this